Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000543577 | SCV000655558 | benign | Progressive myoclonic epilepsy type 8 | 2020-10-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003323454 | SCV004029327 | likely benign | not specified | 2023-07-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003947670 | SCV004764191 | uncertain significance | GDF1-related condition | 2023-11-27 | criteria provided, single submitter | clinical testing | The GDF1 c.925T>C variant is predicted to result in the amino acid substitution p.Ser309Pro. This variant, which was reported as p.S56P, has previously been identified in one individual with tetralogy of Fallot, aortic root dilation, and pulmonary valve stenosis and functional studies in zebrafish found a reduction in TGFβ signaling compared to controls (Karkera et al. 2007. PubMed ID: 17924340). This variant is reported in 0.57% of alleles in individuals of Latino descent in gnomAD; however, quality metrics at this site indicates the frequency estimate may not be reliable. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |